Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment

被引:12
|
作者
Lotrich, Francis E. [1 ]
Germain, Anne [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA
来源
ACTA NEUROPSYCHIATRICA | 2015年 / 27卷 / 01期
基金
美国国家卫生研究院;
关键词
depression; EEG; HCV; hepatitis; psychoneuroimmunology; sleep; SLOW-WAVE SLEEP; COGNITIVE-BEHAVIORAL THERAPY; EEG SPECTRAL-ANALYSIS; NON-REM SLEEP; ELECTROENCEPHALOGRAPHIC SLEEP; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; NEUROBIOLOGICAL MECHANISMS; HEPATITIS-C; NREM SLEEP;
D O I
10.1017/neu.2014.30
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective Although poor sleep accompanies depression, it is unknown which specific sleep abnormalities precede depression. This is similarly the case for depression developing during interferon- (IFN-) therapy. Because vulnerability becomes evident in those who slept poorly before IFN-, we prospectively determined which specific aspect of sleep could predict subsequent depression. Methods Two nights of polysomnography with quantitative electroencephalogram (EEG) were obtained in 24 adult, euthymic subjects - all subsequently treated with IFN- for hepatitis C. Every 2 weeks, a Beck Depression Inventory-II (BDI-II) score was obtained, and the maximal increase in BDI-II from pre-treatment baseline - excluding the sleep question - was determined. Results The delta sleep ratio (DSR; an index of early-night restorative delta power) was inversely associated with BDI-II increases (p<0.01), as was elevated alpha power (8-12 Hz; p<0.001). Both delta (0.5-4 Hz) and alpha power exhibited high between-night correlations (r=0.83 and 0.92, respectively). In mixed-effect repeated-measure analyses, there was an interaction between alpha power and DSR (p<0.001) - subjects with low alpha power and elevated DSR were resilient to developing depression. Most other sleep parameters - including total sleep time and percentage of time in slow wave sleep - were not associated with subsequent changes in depression. Conclusions Both high DSR and low alpha power may be specific indices of resilience. As most other aspects of sleep were not associated with resilience or vulnerability, sleep interventions to prevent depression may need to specifically target these specific sleep parameters.
引用
收藏
页码:14 / 24
页数:11
相关论文
共 50 条
  • [1] Delta Sleep Ratio in Euthymic Individuals Predicts Future Vulnerability to Interferon-alpha-Induced Depression
    Lotrich, Francis E.
    Germain, Anne
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 222S - 222S
  • [2] Depression following pegylated interferon-alpha: Characteristics and vulnerability
    Lotrich, Francis E.
    Rabinovitz, Mordechai
    Gironda, Patricia
    Pollock, Bruce G.
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2007, 63 (02) : 131 - 135
  • [3] Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy
    Scheibel, RS
    Valentine, AD
    O'Brien, S
    Meyers, CA
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 16 (02) : 185 - 191
  • [4] FLUOXETINE TREATMENT OF DEPRESSION CAUSED BY INTERFERON-ALPHA
    LEVENSON, JL
    FALLON, HJ
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1993, 88 (05): : 760 - 761
  • [5] Vulnerability to depression secondary to interferon-alpha: Genetic and personality factors
    Lotrich, FE
    Rabinovitz, M
    Pollock, BG
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S126 - S126
  • [6] MAJOR DEPRESSION SECONDARY TO INTERFERON-ALPHA: MECHANISMS, RESILIENCE, AND VULNERABILITY
    Lotrich, F. E.
    Rabinovitz, M.
    Pollock, B. G.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (03) : 544 - 544
  • [7] Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment
    Franzen, Peter L.
    Buysse, Daniel J.
    Rabinovitz, Mordechai
    Pollock, Bruce G.
    Lotrich, Francis E.
    [J]. PSYCHIATRY RESEARCH, 2010, 177 (1-2) : 240 - 245
  • [8] Tumor Necrosis Factor-Alpha Promoter Polymorphism and Serum Levels Predict Irritable Agitation, but not Depression, during Treatment with Interferon-Alpha
    Lotrich, Francis E.
    Ferrell, Robert
    Pollock, Bruce G.
    [J]. BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 239S - 240S
  • [9] Vulnerability to major depression secondary to interferon-alpha is influenced by serotonergic polymorphisms
    Lotrich, Francis E.
    Pollock, Bruce G.
    Ferrell, Robert E.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 207S - 207S
  • [10] Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism
    Lotrich, Francis E.
    Ferrell, Robert E.
    Rabinovitz, Mordechai
    Pollock, Bruce G.
    [J]. BIOLOGICAL PSYCHIATRY, 2009, 65 (04) : 344 - 348